Publications by authors named "Gregory A Winchell"

Claim this Profile
P
Pharmacokinetic and Exposure Response Analysis of the Double-Blind Randomized Study of Posaconazole and Voriconazole for Treatment of Invasive Aspergillosis.
Johan A Maertens, Galia Rahav, Dong-Gun Lee, Shariq Haider, Isabel Cristina Ramirez-Sanchez, Gregory A Winchell

Clin Drug Investig· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Model-Informed Dose Justifications of Posaconazole in Japanese Patients for Prophylaxis and Treatment Against Fungal Infection.
Takashi Iwasa, Camila de Almeida, Floris Fauchet, Gregory A Winchell, Rik de Greef

J Clin Pharmacol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1b/3 Pharmacokinetics and Safety Study of Intravenous Posaconazole in Adult Asian Participants at High Risk for Invasive Fungal Infections.
Depei Wu, Yingchang Mi, Jianyu Weng, Junling Zhuang, Xiaoyan Ke, Gregory A Winchell

Adv Ther· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and safety of posaconazole intravenous solution and powder for oral suspension in children with neutropenia: an open-label, sequential dose-escalation trial.
Andreas H Groll, Hisham Abdel-Azim, Thomas Lehrnbecher, William J Steinbach, Amanda Paschke, Gregory A Winchell

Int J Antimicrob Agents· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and Safety of Posaconazole Tablet Formulation in Chinese Participants at High Risk for Invasive Fungal Infection.
Kaiyan Liu, Depei Wu, Junmin Li, Hu Chen, Hongmei Ning, Gregory A Winchell

Adv Ther· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and pharmacokinetics of higher doses of caspofungin in healthy adult participants.
Elizabeth M Migoya, Goutam C Mistry, Julie A Stone, Wendy Comisar, Peng Sun, Gregory A Winchell

J Clin Pharmacol· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Model-based decision making in early clinical development: minimizing the impact of a blood pressure adverse event.
Mark Stroh, Carol Addy, Yunhui Wu, S Aubrey Stoch, Nazaneen Pourkavoos, Gregory A Winchell

AAPS J· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of ketoconazole on the pharmacokinetics of a selective alpha 1A-adrenoceptor antagonist.
Gregory A Winchell, Goutam C Mistry, Prasad P Kari, Thomas Marbury, Jutta L Miller

J Clin Pharmacol· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics of indinavir and ritonavir administered at 667 and 100 milligrams, respectively, every 12 hours compared with indinavir administered at 800 milligrams every 8 hours in human immunodeficiency virus-infected patients.
Frank S Rhame, Sandy L Rawlins, Richard A Petruschke, Tara A Erb, Gregory A Winchell

Antimicrob Agents Chemother· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential for interactions between caspofungin and nelfinavir or rifampin.
Julie A Stone, Elizabeth M Migoya, Lisa Hickey, Gregory A Winchell, Paul J Deutsch

Antimicrob Agents Chemother· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Indinavir and rifabutin drug interactions in healthy volunteers.
Walter K Kraft, Jacqueline B McCrea, Gregory A Winchell, Alexandra Carides, Richard Lowry

J Clin Pharmacol· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disposition of caspofungin: role of distribution in determining pharmacokinetics in plasma.
Julie A Stone, Xin Xu, Gregory A Winchell, Paul J Deutsch, Paul G Pearson

Antimicrob Agents Chemother· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single- and multiple-dose pharmacokinetics of caspofungin in healthy men.
Julie A Stone, Sherry D Holland, Peter J Wickersham, Andrew Sterrett, Michael Schwartz, Gregory A Winchell

Antimicrob Agents Chemother· March 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cyclobenzaprine pharmacokinetics, including the effects of age, gender, and hepatic insufficiency.
Gregory A Winchell, Joyce D King, Cynthia M Chavez-Eng, Marvin L Constanzer, Scott H Korn

J Clin Pharmacol· January 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis